White Papers

Increasing Drug Impact Through Patient Support Programs

Posted by |

Patient empowerment is on the rise and it has become increasingly important for drug companies to develop patient-centric approaches that include the redesign of patient support programs to increase product loyalty and prevent patients from switching to competing products. Initially, companies offered patient support programs to improve access to and usage of drugs and adherence to drug protocols; recently, these programs have expanded.

In turn, pharmaceutical and other health companies need to shift their approach to the marketplace to satisfy patient demands.


Download the Whitepaper:

Tags: , , ,

Related Resources

Read More

The FinTech Payment Story

Robert H. Goddard, the father of modern rocket propulsion said, “It is difficult to say what is impossible, for the […]

Read More

Demand Optimization and Supply Chain Resilience in a Disrupted World

In 2020 and 2021, most companies flew blind into the black swan event of the pandemic, unprepared, despite the data, […]

Read More

Scenario Planning For the Post-COVID World – White Paper

While we can’t predict the future, we can consider a range of realistic possibilities with a structured scenario planning framework.

Subscribe to our mailing list for our latest updates: